Crawford Investment Counsel Inc
Source: SEC Form 13F · as of Mar 2026Crawford Investment Counsel Inc holds 18 biotech & pharma companies tracked by BioSniper, totaling $846.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$846.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 886,415 | $192.8M |
| AZNASTRAZENECA PLC | 744,724 | $146.9M |
| PMPhilip Morris International Inc | 759,452 | $125.6M |
| JNJJOHNSON & JOHNSON | 415,868 | $101.7M |
| DGXQuest Diagnostics Incorporated | 486,433 | $95.3M |
| PFEPFIZER INC | 1,991,614 | $55.9M |
| CAHCardinal Health Inc. | 211,722 | $44.7M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 636,839 | $35.1M |
| MRKMerck & Co., Inc. | 148,066 | $17.8M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 187,506 | $10.4M |
| LLYELI LILLY & Co | 9,199 | $8.5M |
| ABTABBOTT LABORATORIES | 36,298 | $3.7M |
| AMGNAMGEN INC | 7,777 | $2.7M |
| GILDGILEAD SCIENCES, INC. | 17,530 | $2.4M |
| ZBHZimmer Biomet Holdings Inc. | 15,387 | $1.4M |
| PRGOPERRIGO Co plc | 51,270 | $551K |
| BMYBRISTOL MYERS SQUIBB CO | 7,756 | $470K |
| ELVElevance Health Inc. | 870 | $255K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.